Lion Biotechnologies (LBIO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts LBIO Hot Sheet
Join SI Premium – FREE
Lion Biotechnologies (NASDAQ: LBIO) reported Q1 Adj. EPS of ($0.28), in-line with the analyst estimate of ($0.28).
For earnings history and earnings-related data on Lion Biotechnologies (LBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
- Okta upgraded as AI security opportunity boosts outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
